SUBSCRIBE TO OUR NEWSLETTER

Resources

The Bracken Group
Recent Posts
6 April 2022

Cancer Moonshot FDA Guidelines Update

The Bracken Group
1 February 2022

Get to Know Wil Reinus, M.D., Partner and Consultant with The Bracken Group

The Bracken Group
15 January 2022

Get to Know Victor Miranda, M.D., Partner and Consultant with The Bracken Group

The Bracken Group
14 January 2022

Remembering 2021, Predicting 2022

The Bracken Group
16 November 2021

A Novel Read Methodology in Nuclear Medicine in Neuroendocrine Tumors

The Bracken Group
11 November 2021

The Challenge in Creating Ethical Pharmaceuticals from Cannabinoids

The Bracken Group
20 October 2021

Falgun Chokshi, M.D., Joins Bracken as Partner

The Bracken Group
12 October 2021

Reporting on a Phase II Study to Determine the Optimal Dosing Regimen for ⁶⁸Ga-satoreotide Trizoxetan As An Imaging Agent in Gastroenteropancreatic Neuroendocrine Tumors

The Bracken Group
5 October 2021

Get to Know Andrew Salzman, M.D., Partner and Consultant with The Bracken Group

The Bracken Group
27 September 2021

Why Readers Vary in Interpreting Clinical Trial Images, and When to Worry About It

The Bracken Group
CONTACT US

Ask us anything.

We would be delighted to hear from you and discuss our consulting services. Please call +1 215 648 1208 to chat with us directly. Or write to us using the form provided here. We look forward to collaborating with you.
It's almost like getting free consulting...

Subscribe to our monthly hand-crafted newsletter for the latest insights on clinical trial trends and the life science industry.

Subscribe Now  

12 Penns Trail, Newtown, PA 18940
+1 215 648 1208

© 2022 the bracken group - Privacy Policy

12 Penns Trail, Newtown, PA 18940
+1 215 648 1208

© 2022 the bracken group - Privacy Policy